Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Pregabalin on heart rate?Clinical study of xofigo radium 223 dichloride phase 1 2?Who owns ivermectin patent?Acetaminophen earliest patent expiry?Sevelamer patent expiration time?
See the DrugPatentWatch profile for skyrizi
Skyrizi (risankizumab) became available in the United States in 2019, after its FDA approval that year. [1]
The FDA approval is the key milestone tied to “became available” in the U.S. The exact release date can vary by country and by when pharmacies began stocking it, but the approval year referenced for availability is 2019. [1]
Other Questions About Skyrizi :